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Abstract
The human immunity-related GTPase M (IRGM) has been shown to be critically involved in regulating autophagy as a means
of disposing cytosolic cellular structures and of reducing the growth of intracellular pathogens in vitro. This includes
Mycobacterium tuberculosis, which is in agreement with findings indicating that M. tuberculosis translocates from the
phagolysosome into the cytosol of infected cells, where it becomes exposed to autophagy. To test whether IRGM plays a
role in human infection, we studied IRGM gene variants in 2010 patients with pulmonary tuberculosis (TB) and 2346
unaffected controls. Mycobacterial clades were classified by spoligotyping, IS6110 fingerprinting and genotyping of the
pks1/15 deletion. The IRGM genotype 2261TT was negatively associated with TB caused by M. tuberculosis (OR 0.66, CI 0.52–
0.84, Pnominal 0.0009, Pcorrected 0.0045) and not with TB caused by M. africanum or M. bovis (OR 0.95, CI 0.70–1.30. P 0.8).
Further stratification for mycobacterial clades revealed that the protective effect applied only to M. tuberculosis strains with
a damaged pks1/15 gene which is characteristic for the Euro-American (EUAM) subgroup of M. tuberculosis (OR 0.63, CI 0.49–
0.81, Pnominal 0.0004, Pcorrected 0.0019). Our results, including those of luciferase reporter gene assays with the IRGM variants
2261C and 2261T, suggest a role for IRGM and autophagy in protection of humans against natural infection with M.
tuberculosis EUAM clades. Moreover, they support in vitro findings indicating that TB lineages capable of producing a
distinct mycobacterial phenolic glycolipid that occurs exclusively in strains with an intact pks1/15 gene inhibit innate
immune responses in which IRGM contributes to the control of autophagy. Finally, they raise the possibility that the
increased frequency of the IRGM 2261TT genotype may have contributed to the establishment of M. africanum as a
pathogen in the West African population.
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Introduction
Autophagy is induced by the formation of intracellular double-
membrane structures which form autophagosomes to sequester
and, after further maturation to autolysosomes, degrade cytosolic
protein aggregates and corrupted cellular organelles. Thereby, it
allows a re-cycling of amino acids, which is of particular
importance during periods of cell starvation. Autophagy is also
an efficient innate defense mechanism in that it may lead to
deposition of intracellular pathogens into an autophagosome for
subsequent autolysosomal acidification and peptidase-mediated
degradation. The net effect of well functioning autophagy is
protein degradation, optimized loading of Human Leukocyte
Antigen (HLA) class II molecules and intensified antigen
presentation [1].
The activation pathways of autophagy and phagocytosis are
closely related in that they share phosphatidylinositol-3-phosphate
(PI3P) and other factors in facilitating the fusion step and closure
of the phagophore at the final stage of phagosome and
autophagosome formation [2]. Among other factors, immunity-
related GTPases exert significant effects on both autophagy and
phagosome maturation [3]. It was recently shown in human U937
cells that inhibition of the immunity-related GTPase IRGM by
siRNA caused impaired conversion of light chain 3 (LC3), an
exclusive marker of the autophagy cascade, into its active form
which is required for the elongation of the double membranes and
PLoS Pathogens | www.plospathogens.org 1 September 2009 | Volume 5 | Issue 9 | e1000577eventual completion of the autophagosome [4]. In these
experiments, impaired LC3 conversion resulted also in an
extended survival of BCG in phagosomes. These experiments
were based on earlier experiments in mice where Irgm1 (syn.:
LRG-47; encoded by Irgm1), the murine homologue of IRGM,
was critically involved through induction of autophagy in the
control of several intracellular pathogens, including Mycobacterium
bovis BCG and M. tuberculosis H37rv [1,3,5,6]. Notably, phagosome
development into phagolysosomes may alternatively be induced by
the autophagic component LC3 even when the conventional PI3P
dependent pathway of phagosome maturation is blocked by
experimental infection with the M. tuberculosis H37rv strain [3].
IRGM (syn: LRG47, IFI1) is encoded by the immunity-related
GTPase protein family, M gene (IRGM; 5q33.1; OMIM *608212).
IRGM consists ofa long first exon encoding 181 amino acids, and four
shorter putative exons that span more than 50 kilobases (kb)
downstream of the first exon [7]. Most recent evidence indicates
that the IRGM gene was deactivated during evolution but has
regained its function after the insertion of a retroviral ERV9 segment
and an Alu repeat sequence (Figure 1; [8]). Genetic variants of IRGM,
including a 20.1 kilo-base (kb) upstream deletion polymorphism,
have been found to confer in Caucasians an increased risk of
developing Crohn’s disease, whereby coding-sequence variation has
been excluded to be the liable source of the association [9–11].
The phylogenetic tree of the M. tuberculosis complex contains two
independent clades. Clade 1 represents all M. tuberculosis sensu strictu
lineages that may be exclusively pathogenic for humans, while
clade 2 comprises lineages that are pathogenic for both humans
and animals (M. africanum, M. bovis) [12]. A major branch of M.
tuberculosis sensu strictu is the M. tuberculosis Euro-American (EUAM)
lineage that recently was shown to be prevalent and cause
significant numbers of infections in West Africa as well [13]. While
M. tuberculosis lineages occur throughout the world, M. africanum
strains are almost exclusively restricted to West Africa [12,14],
suggesting the existence of factors favoring spread and preserva-
tion of M. africanum in West Africa.
Based onthe invitro evidence ontherole ofIRGMand autophagy
in experimental M. tuberculosis infections of murine and human cells
[3,4] we hypothesized that naturally occurring IRGM variants,
including the large upstream 20.1 kb deletion, might also be
relevant to the phenotype of in vivo human pulmonary tuberculosis
(TB). We have, in a case-control design, re-sequenced fragments of
the IRGM gene and genotyped distinct genetic variants. An
influence exerted by these variants on susceptibility or resistance
to TB should be reflected in a large sample of active sputum-positive
cases with pulmonary TB that we collected in Ghana, West Africa,
and compared it to a control group of notable size.
Results
Power of the association study, Hardy-Weinberg
equilibrium
A power of .90% of detection was achieved for multiplicative
and additive models, assuming an approximative TB prevalence of
0.004 in West Africa, a frequency of 0.1 for high risk alleles, and a
genotype relative risk of 1.3 (a=0.05) with our sample size (case-
control ratio=1.18).
All variants tested were in HWE in cases and controls except
IRGM 2261 and IRGM 271, where the distribution of alleles was
in HWE among cases, but deviated in controls. The deviation
could be traced to the subgroup of controls of Ewe ethnic
background. As IRGM 2261 and IRGM 271 are in strong LD but
were determined by independent genotyping assays, a genotyping
failure appears to be highly unlikely. The most plausible
explanation is that the deviation results from the low number of
Ewe controls (5%). Calculational exclusion of this subgroup from
statistical analyses did not affect the significance of our results.
As data on the frequency of the IRGM 2261T variant in other
ethnic groups are not available so far, we have typed this variant
also in a small panel of 47 healthy Caucasian subjects. The
genotypes CC, CT and TT were observed at frequencies of 0.81,
0.15 and 0.04, respectively, versus frequencies of 0.44, 0.43 and
0.13 in the Ghanaian study population. Although not represen-
tative due to the low number of Caucasian individuals and to the
bias imposed by a non-randomly selected African study group, the
data suggests that the IRGM 2261T allele occurs by far more
frequently among West Africans.
Novel IRGM variants and genotypes identified by re-
sequencing
Re-sequencing revealed, in addition to previously recognized
polymorphisms, ten yet unidentified IRGM variants which were
submitted to the NCBI dbSNP database (Table 1). The positions and
preliminary NCBI ss numbers of the novel variants are as follows:
IRGM 2908A.C (ss105106760), 2797C.T (ss105106761),
2420C.T (ss105106763), 2284G.A (ss105106764), 281C.A
(ss105106765), 370A.G (ss105106766), IRGM intron +2T.C
(ss105106767), intron +106T.C (ss105106768) and a deletion of
two bases at positions 2386/2387delAG (ss105106769). A tetranu-
cleotide polymorphism (rs60800371; repeats starting at nucleotide
position 2308) was newly recognized to appear as triple repeat. This
variant is located at the 59-end of the Alu segment (Figure 1; [15]).
Potential accumulation of transcription factor binding sites (FOXP3,
GR, PR A/PR B) may occur, depending on the number of
tetranucleotide repeats. All novel variants were confirmed by forward
and reverse DNA sequencing and were observed in at least two
different DNA samples. The IRGM genotypes identified by re-
sequencing of 69 DNA samples are given in Table 1.
Mycobacterial genotypes
Out of the total of 1567 isolates that were obtained and
characterized, 1029 (65.7%) were M. tuberculosis Euro-American
Author Summary
Autophagy is a process in which cell components are
degraded by the lysosomal machinery. It has recently been
described that activation of autophagy reduces the viability
of M. tuberculosis in phagosomes due to an intimate
autophagy-phagocytosis interaction. M. tuberculosis may
also be directly accessible to autophagy, as M. tuberculosis
was found to translocate into the cytoplasm. The immunity-
related GTPase IRGM is a mediator of innate immune
responses and induces autophagy. We have studied genetic
variants ofthehumanIRGMgene ina Ghanaian tuberculosis
case-control group and found that the IRGM variant 2261T
provides relative protection against disease when the
infection is caused by the Euro-American lineage of M.
tuberculosis. This lineage is characterized by the pks1/15
seven base-pair (bp) deletion.Theproduct of an intact pks1/
15 gene, phenolic glycolipid-tb, might contribute to
mycobacterial virulence by suppressing innate immune
responses. It is, therefore, conceivable that only the Euro-
American lineage is exposed to IRGM-triggered innate
defence mechanisms. Our observations suggest that the
increased frequency of the IRGM 2261TT genotype may
have allowed the establishment of M. africanum as a
pathogen in West Africa.
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were M. africanum, and 10 (0.6%) were M. bovis (the latter two
lineages exhibiting the RD9 deletion). Fifty-six (3.6%) isolates
belonged to the M. tuberculosis East-African-Indian (EAI), Beijing or
Delhi lineages.
Allele, genotype and haplotype associations
Genotyping of eight IRGM variants was performed in 2010
HIV-negative TB cases and 2346 controls. The genotyping
detection rate was .94% for all variants.
In the entire study group, no allelic or genotypic association
with disease or resistance was observed. A trend for an association
with resistance to TB was, however, seen for the distribution of the
IRGM 2261TT genotype (OR 0.79, CI 0.65–0.96, uncorrected
nominal P value [Pnom] 0.017; Table 2). Stratification for the two
major phylogenetic mycobacterial clades, M. tuberculosis sensu strictu
and M. africanum/M. bovis, revealed a significant difference in the
distribution of the IRGM 2261 genotype among cases and
controls. IRGM 2261TT was significantly associated with
protection from TB caused by M. tuberculosis, but not by M.
africanum/M. bovis (OR 0.66, CI 0.52–0.84, Pnom 0.0009, Pcorr
0.0045 vs. OR 0.95, CI 0.70–1.30, Pnom 0.8). The association was
confirmed in additive and recessive statistical models (ORadd 0.86,
CI 0.77–0.95, Pcorr 0.025 and ORrec 0.68, CI 0.53–0.85, Pcorr
0.005, respectively; Table 3). Further stratification with respect to
mycobacterial genotypes revealed that the association of the
2261TT genotype applied exclusively to carriers of the M.
tuberculosis Euro-American (EUAM) genotype, but not to individ-
uals infected with M. tuberculosis East-African-Indian (EAI), Beijing
or Delhi genotypes (OR 0.63, CI 0.49–0.81, Pnom 0.0004, Pcorr
0.0019 vs. OR 1.20, CI 0.57–2.52, Pnom 0.6). Again, the
association was substantiated in the additive and recessive models
(ORadd 0.85, CI 0.76–0.95, Pcorr 0.016 and ORrec 0.64, CI 0.50–
0.82, Pcorr 0.0017, respectively; Table 4). No association was
observed for carriers of the heterozygous IRGM 2261CT
genotype (OR 0.96, CI 0.82–1.13, P 0.6).
For the low numbers of patients infected with mycobacteria of
the EAI/Bejing/Delhi group, the statistical power might not allow
to obtain significant results and a possible association could be
easily overlooked. To rule out this possibility statistically, a
supplementary test of interaction was performed [16]. This test
permitted to verify complete independence of ORs and validation
of the exclusive liability of the M. tuberculosis EUAM genotype for
the observed association. Cluster analyses of cases were done as
previously described [17]. The distribution of the two variants at
IRGM position 2261 among and within clusters of cases did not
differ significantly. This applied also when stratifications for
ethnicity were performed.
Haplotypes and linkage disequilibria (LD) were reconstructed
with the UNPHASED and Haploview softwares, respectively
(Table 5, Figure 1). The corrected global P value of 0.017 for
haplotypes after 1000 permutations comprising all variants that
Figure 1. Schematic structure of the IRGM gene. A) Gene segments with lengths and all SNPs that are recognized so far are given. SNPs
associated with Crohn’s Disease, SNPs genotyped in the present study and the SNP associated with protection from TB caused by the EUAM-lineage
of M. tuberculosis are indicated. The nucleotide positions of SNPs indicated by rs/ss numbers are listed in Table 1. B) Estimates of pairwise linkage
disequilibria (LD) between IRGM variants with the LD measure of r
2 assuming Hardy-Weinberg equilibrium. C) Potential loss of transcription factor
binding sites (ARNT, PAX5, AHR) in sequences carrying the IRGM 2261T allele. D) Potential accumulation of transcription factor binding sites (FOXP3,
GR, PR A/PR B), depending on the number of tetranucleotide repeats (rs60800371; [15]).
doi:10.1371/journal.ppat.1000577.g001
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also to a distinct haplotypic combination. Detailed analyses
including 1000 permutations for each combination showed that
the IRGM haplotype 20kbdel_DEL/24299C/2566G/2420C/
rep4/2261T/271A/313T was associated with resistance to TB
caused by EUAM strains (OR 0.83, CI 0.73–0.93, P 0.001;
Table 5), albeit the haplotype was not found to exert a stronger
effect than the 2261T variant alone when occurring homozy-
gously (Tables 4 and 5). This underscores the significance of the
IRGM 2261TT genotype in protection from human pulmonary
tuberculosis caused by the species M. tuberculosis.
Reporter gene assay
A two-tailed student’s t-test revealed a significant difference in
the normally distributed ratio of firefly:Renilla luciferase activity of
five independent transfections per IRGM variant in the luciferase
reporter gene assay, indicating increased gene expression in cells
transfected with pGL3-Control Vector carrying the mutant
variant IRGM-261T than in cells transfected with the pGL3-
Control Vector with the IRGM wild-type variant (2261C)
(P=0.013) (Figure 2).
Discussion
We found in a large Ghanaian study group of HIV-negative
patients with pulmonary TB and healthy control individuals that a
distinct IRGM genotype, IRGM 2261TT, was as a trend
associated with decreased susceptibility to TB. After stratification
for the two major mycobacterial clades and molecular subtypes the
trend observed in the entire study group could be traced back to
an association of IRGM 2261TT with tuberculosis exclusively
when caused by the M. tuberculosis EUAM lineage. No association
was observed in comparisons of cases caused by M. tuberculosis EAI,
Beijing, Delhi and M. africanum/M. bovis with controls. The
frequencies of the synonymous variant 313T.C, the variant at
position 24299 and of the 20.1 kb deletion, all found to be
associated with Crohn’s disease in other studies [9–11], did not
differ significantly between TB patients and controls.
Upon infection of macrophages, M. tuberculosis initially resides in
phagosomes. During their normal maturation, phagosomes fuse with
lysosomes and establish a hostile environment for the pathogen,
characterized by lysosomal enzymes, acid pH, reactive oxygen and
nitrogen intermediates, and toxic peptides. Most macrophage
mediated killing of intracellular pathogens occurs within the
phagolysosome and pathogens have developed several mechanisms
to avoid this vacuolar attack by escape and multiplication in the
cytoplasm, inhibition of phagosome-lysosome fusion or circumvent-
ing the common endocytic pathway (reviewed in [18]). With regard
to M. tuberculosis H37Rv, translocation of the bacteria from
phagosomes to cytosolic compartments has been observed to occur
in nonapoptotic cells [19]. Notably, escape into the cytosol has also
been observed of the M. tuberculosis strain CDC1551 in laboratory
infections of the amoeba Dictyostelium discoideum [20] and loss of
phagosomal membranes with release of mycobacteria has been
observed in an in vitro system five days post infection [21].
Autophagy induced by IRGM can efficiently interfere with
cytosolic replication of pathogens by trapping and recapture and
subsequent degradation of bacteria [22,23]. In the LC3 dependent
activation pathway, induction of autophagy contributes not only to
the degradation of cytosolic components, but also to the
maturation of mycobacterial phagosomes [3,4]. While M.
tuberculosis can impair phagosome maturation by blocking the
normal PI3P dependent pathway, this effect is restored and
outbalanced by the alternate activation mode triggered by LC3.
This is consistent with the finding in mice and in human U937
cells that murine Irgm1 and human IRGM, respectively, play an
important role in the containment of M. tuberculosis through
efficient induction of autophagy [4].
The polymorphism that is associated with relative resistance to
TB, IRGM 2261T, in particular when occurring homozygously as
TT genotype, might enhance expression of the mature IRGM
protein which triggers autophagic degradation of translocated
bacteria. The transcription factor AHR is expressed in the
monocytic cell line THP1 that we used in our transfection
experiments and inhibits differentiation of monocytes in vitro
[24,25]. This suggests that an unaffected AHR/ARNT transcrip-
tion factor complex that is likely to occur in the IRGM wild-type
gene promoter, may decrease innate immune responses mediated
by macrophages. Inversely, and based on our luciferase reporter
gene assays, the loss of the potential PAX5, AHR and ARNT
transcription factor binding sites predicted for the IRGM variant
2261T upstream of the coding region is likely to contribute to
increased IRGM gene expression and, thus, enhanced innate
responses. The fact that IRGM is not inducible by IFN-c as are Irg
genes in mice [4,7,26] but initiates successfully autophagy as does
IFN-c, argues for additional resistance mechanisms in individuals
carrying the IRGM 2261T variant homozygously, independent of
other Th1-mediated immune responses.
The association that we observed was restricted to infections
caused by the M. tuberculosis EUAM lineage. The major
characteristic of that lineage is the pks1/15 7 bp deletion which
does not occur in M. africanum, M. bovis and in the other M.
tuberculosis lineages identified in our study, EAI, Beijing, and Dehli.
Table 1. IRGM variants and minor allele frequencies identified
by re-sequencing.
Localization rs-/ss number Substitution MAF
59-UTR 2964 rs10059011 A.C 0.46 (A)
59-UTR 2908* ss105106760 A.C 0.01 (C)
intron 2844 rs10052068 T.C 0.23 (C)
intron 2797* ss105106761 C.T 0.06 (T)
intron 2787 rs17111376 T.C 0.5
intron 2566 rs17111379 G.C 0.21 (C)
intron 2420* ss105106763 C.T 0.06 (T)
59-UTR 2386/387* ss105106769 AG.del 0.04 (del)
Alu sequence 2308
#* rs60800371 1, 3 or 4 ‘GTTT’
Alu sequence 2284* ss105106764 G.A 0.04 (A)
Alu sequence 2261 rs9637876 C.T 0.31 (T)
Alu sequence 271 rs9637870 G.A 0.31 (A)
exon 1 281* ss105106765 C.A 0.01 (C)
exon 1 313 rs10065172 C.T 0.49 (T)
exon 1 370* ss105106766 A.G 0.01 (G)
Intron +2* ss105106767 T.C 0.01 (C)
Intron +87 rs7705542 G.A 0.49 (G)
Intron +106* ss105106768 T.C 0.01 (C)
Positions refer to the reference sequence and are given relative to the ATG start
codon (reference sequence: chromosome 5 contig, GenBank accession number
NW_922784.1, region 23935681…23938058; contains at position 2308 one
‘GTTT’ motif). MAF, minor allele frequency; *, novel variant identified in the
present study population;
#, microsatellite repeat of 1, 3 or 4 ‘GTTT’ tandem
motifs.
doi:10.1371/journal.ppat.1000577.t001
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GT Cases (%) Controls (%) OR CI Pnom Pcorr ORadd CI Pnom Pcorr ORrec CI Pnom Pcorr
All genotypes
deletion
WT/WT 484 (24.7) 577 (25.2) 1 0.97 [0.89–1.05] 0.4 0.90 [0.78–1.04] 0.2
WT/DEL 1009 (51.5) 1131 (49.4) 1.05 [0.90–1.22] 0.524
DEL/DEL 466 (23.8) 584 (25.5) 0.93 [0.78–1.11] 0.430
24299 CC 545 (27.8) 677 (29.9) 1 1.05 [0.97–1.15] 0.2 1.03 [0.89–1.19] 0.7
CT 989 (50.4) 1104 (48.8) 1.11 [0.97–1.28] 0.14
TT 429 (21.9) 484 (21.4) 1.10 [0.93–1.31] 0.3
2566 CC 117 (6.0) 118 (5.2) 1 0.99 [0.89–1.09] 0.8 1.01 [0.89–1.14] 0.8
CG 703 (36.1) 855 (37.3) 0.84 [0.64–1.11] 0.2
GG 1125 (57.8) 1318 (57.5) 0.87 [0.66–1.14] 0.3
2420 CC 1787 (90.5) 2109 (91.6) 1 1.18 [0.96–1.46] 0.12 nc
CT 186 (9.4) 193 (8.4) 1.16 [0.94–1.43] 0.18
TT 2 (0.1) 0 (0.0) nc
repeat* 1/1 353 (18.2) 411 (18.1) 1 0.97 [0.94–1.01] 0.1 0.96 [0.93–1.00] 0.05
#
1/3 386 (19.9) 416 (18.4) 1.09 [0.89–1.33] 0.4
1/4 602 (31.0) 687 (30.3) 1.03 [0.86–1.23] 0.8
3/3 88 (4.5) 117 (5.2) 0.89 [0.65–1.22] 0.5
3/4 272 (14.0) 305 (13.5) 1.04 [0.84–1.29] 0.7
4/4 243 (12.5) 331 (14.6) 0.86 [0.69–1.07] 0.17
2261 CC 901 (45.2) 1011 (43.5) 1 0.91 [0.84–0.99] 0.04 0.80 [0.67–0.96] 0.015
CT 862 (43.3) 988 (42.5) 0.98 [0.86–1.11] 0.7
TT 229 (11.5) 324 (14.0) 0.79 [0.65–0.96] 0.017
271 GG 372 (39.0) 856 (38.9) 1 0.97 [0.89–1.06] 0.5 0.85 [0.71–1.01] 0.07
AG 465 (48.7) 999 (45.4) 1.08 [0.94–1.23] 0.290
AA 118 (12.4) 347 (15.8) 0.89 [0.73–1.07] 0.215
313 TT 280 (27.9) 675 (29.2) 1 1.04 [0.95–1.13] 0.4 1.01 [0.87–1.17] 0.9
TC 506 (50.4) 1144 (49.5) 1.09 [0.94–1.25] 0.2
CC 218 (21.7) 491 (21.3) 1.07 [0.90–1.27] 0.5
GT, genotype; OR, odds ratio; CI, 95% confidence interval; ORadd, estimates of an additive genetic model. ORrec estimates of a recessive genetic model; Pnom nominal P
value; Pcorr, P value after Bonferroni correction (correction factor=5); WT, wild-type, no deletion); DEL, 20.1 kb deletion; nc, not calculable.
*number of tandem repeats given in digits.
#homozygous 4/4 genotype compared to all other combinations.
P values are adjusted for age, gender and ethnicity.
doi:10.1371/journal.ppat.1000577.t002
Table 3. IRGM 2261 genotype associations after stratification for the two major groups of M. tuberculosis and M. africanum/
M.bovis.
GT Cases (%) Controls (%) OR CI Pnom Pcorr ORadd CI Pnom Pcorr ORrec CI Pnom Pcorr
M. tuberculosis
2261 CC 502 (46.8) 1011 (43.5) 1 0.86 [0.77–0.95] 0.005 0.025 0.68 [0.53–0.85] 0.001 0.005
CT 464 (43.3) 988 (42.5) 0.95 [0.82–1.11] 0.6
TT 106 (9.9) 324 (14.0) 0.66 [0.52–0.84] 0.0009 0.0045
M. africanum/M. bovis
2261 CC 204 (42.5) 1011 (43.5) 1 1.00 [0.87–1.15] 0.99 0.99 [0.89–1.10] 0.9
CT 214 (44.6) 988 (42.5) 1.07 [0.86–1.32] 0.5
TT 62 (12.9) 324 (14.0) 0.95 [0.70–1.30] 0.8
GT, genotype; OR, odds ratio; CI, 95% confidence interval; ORadd, estimates of an additive genetic model. ORrec estimates of a recessive genetic model; Pnom nominal P
value; Pcorr, P value after Bonferroni correction (correction factor=5). P values are adjusted for age, gender and ethnicity.
doi:10.1371/journal.ppat.1000577.t003
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against disease caused by the lineage that exhibits the pks1/15
deletion remains to be explained further. One may hypothesize
that absence or presence of the pks1/15 deletion may contribute to
a modulation of the pathogenic potential of infecting strains in
different ethnicities, leading to an adaption of mycobacterial
lineages to their sympatric host population. Inhibition of innate
immune responses and a tendency of increased spread of bacteria
by phenolic glycolipid TB (PGL-tb), the product of undamaged
pks1/15 gene, has been demonstrated [27,28]. It is, therefore,
reasonable to assume that lineages which do not produce PGL-tb
as a suppressor of the innate immune response are more
susceptible to IRGM-triggered innate immune mechanisms,
namely phagosome maturation and autophagy. However, a more
recent report indicates that PGL-tb itself does not confer
hypervirulence, but rather differentially may modulate early
cytokine response of the host [29]. As such, variable PGL-tb
levels in conjunction with other yet inadequately defined
mycobacterial virulence factors might result in a lineage-specific
immunogenicity and/or degree of virulence that is related to the
occurrence of human genetic variants in a particular population
(14,29). Since translocation of bacteria from the phagosome has
only been observed for M. tuberculosis H37rv and M. leprae, but not
for M. bovis BCG [19], and was not tested for other lineages it is
also conceivable that distinct pathogenic strains are subjected to
mechanisms preventing translocation to cytosolic compartments
and allowing escape from autophagy, a hypothesis that awaits
further substantiation.
This would support the view of increased virulence of lineages
carrying intact pks1/15 genes such as M. tuberculosis Beijing and
other lineages, but also underline the equivalent pathogenic
potential of M. africanum compared to M. tuberculosis as has been
Table 4. IRGM 2261 genotype associations after stratification for strains positive and negative for the mycobacterial pks1/15
deletion.
GT Cases (%) Controls (%) OR CI Pnom Pcorr ORadd CI Pnom Pcorr ORrec CI Pnom Pcorr
M. tuberculosis EUAM
2261 CC 476 (46.9) 1011 (43.5) 1 0.85 [0.76–0.95] 0.003 0.016 0.64 [0.50–0.82] 0.0003 0.0017
CT 444 (43.7) 988 (42.5) 0.96 [0.82–1.13] 0.6
TT 96 (9.5) 324 (14.0) 0.63 [0.49–0.81] 0.0004 0.0019
M. tuberculosis EAI/Beijing/Delhi
2261 CC 26 (46.4) 1011 (43.5) 1 1.02 [0.70–1.49] 0.93 1.35 [0.67–2.70] 0.4
CT 20 (35.7) 988 (42.5) 0.78 [0.43–1.41] 0.4
TT 10 (17.9) 324 (14.0) 1.20 [0.57–2.52] 0.6
GT, genotype; OR, odds ratio; CI, 95% confidence interval; ORadd, estimates of an additive genetic model. ORrec estimates of a recessive genetic model; Pnom nominal P
value; Pcorr, P value after Bonferroni correction (correction factor=5). EUAM, Euro-American lineages of Mycobacterium tuberculosis; EAI, East-African-Indian lineages of
Mycobacterium tuberculosis. P values are adjusted for age, gender and ethnicity.
doi:10.1371/journal.ppat.1000577.t004
Table 5. IRGM haplotype associations (8 polymorphisms).
Haplotype Cases Controls OR CI Pnom
Del 24299 2566 2420 rep 2261 271 313 n (%) n (%)
M. tuberculosis EUAM
WT C G C 3 C G T 28 (1.5) 65 (1.5) 1.06 [0.66–1.70] 0.8
WT C G C 4 T A T 45 (2.3) 97 (21.9) 1.16 [0.80–1.69] 0.4
WT T C C 1 C A C 24 (1.2) 50 (1.1) 0.98 [0.54–1.78] 0.95
WT T C C 1 C G C 452 (23.5) 1009 (22.8) 1.05 [0.92–1.20] 0.4
WT T G C 1 C A C 37 (1.9) 39 (0.9) 1.93 [1.14–3.27] 0.01
WT T G C 1 C G C 340 (17.7) 784 (17.7) 1.00 [0.87–1.16] 0.96
WT T G C 3 C G C 37 (1.9) 102 (2.3) 0.84 [0.57–1.23] 0.3
WT T G C 4 C G C 28 (1.5) 52 (1.2) 1.25 [0.78–2.01] 0.4
DEL C G C 3 C A T 25 (1.3) 37 (0.8) 1.38 [0.75–2.53] 0.3
DEL C G C 3 C G T 264 (13.7) 553 (12.5) 1.10 [0.93–1.29] 0.3
DEL C G C 4 T A T 554 (28.8) 1459 (32.9) 0.83 [0.73–0.93] 0.001
DEL C G T 3 C G T 94 (4.9) 176 (3.9) 1.26 [0.97–1.63] 0.09
EUAM, Euro-American lineages of Mycobacterium tuberculosis; del, deletion; rep, repeat (number of tetranucleotide repeats given in digits; see also Figure 1); OR, odds
ratio; CI, 95% confidence interval; Pnom, nominal P value; WT, wild-type; DEL, 20.1 kb deletion. P values refer to comparisons of one haplotype to all other combinations
and are adjusted for age, gender and ethnicity. Corrected global P value in cases caused by EUAM infections after 10000 permutations=0.02. Missing genotypes are
compensated for by simulations of all possible completions of the data.
doi:10.1371/journal.ppat.1000577.t005
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the high prevalence of IRGM 2261TT in our Ghanaian study
population and the relative protection that it confers from TB
caused by M. tuberculosis EUAM might reflect one of multiple
selection factors which promote the preferential and virtually
exclusive propagation of M. africanum in West Africa, an
assumption to be verified in other data sets of mycobacterial and
human genotypes which are not yet available. The phylogeo-
graphy of mycobacteria implies that lineages have become
differentially adapted to different ethnicities with allelic variations
conferring traits associated with certain infection phenotypes [14].
While the association of the IRGM polymorphism that we found
cannot unquestionably confirm the role of IRGM in tuberculosis, it
adds evidenceto the invivo experiments in mice and human cells [3,4]
and supports the relevance of autophagy in the control of
tuberculosis. Unfortunately, genetic replication data on the role of
human IRGM polymorphism in infections caused by M. tuberculosis
subtypes that have unambiguously been determined by mycobacte-
rial genotyping are not available so far, neither for Caucasian nor for
African or Asian study groups. Data of functional experiments on the
effect of IRGM in tuberculosis caused by strains that produce PGL-tb
a r en o ta v a i l a b l e .T h ei n h i b i t i o no ft h ei n n a t ei m m u n em e d i a t o r s
TNF-alpha and other interleukins by PGL-tb has been described
earlier [26]. A corresponding inhibition of IRGM would explain our
findings and contribute to understanding the role of PGL-tb as a
factor of virulence and modulator of innate immune responses.
Materials and Methods
Ethics statement
The study protocol was approved by the Committee on Human
Research, Publications and Ethics, School of Medical Sciences,
Kwame Nkrumah University, Kumasi, and the Ethics Committee
of the Ghana Health Service, Accra. Patients were treated
according to the ‘‘Directly Observed Treatment, Short-course’’
(DOTS) strategy organized by the Ghanaian National Tubercu-
losis Programme. Blood samples for genetic analyses and HIV
testing were taken only after a detailed explanation of the study
aims and written or thumb-printed consent for participation
provided, including HIV testing.
Patients and controls
Study participants were recruited in Ghana, West Africa,
between September 2001 and July 2004. The recruitment area
and the enrollment procedure have previously been described
[17,30]. Patients were enrolled at the two Teaching Hospitals in
Accra and Kumasi and at additional hospitals or policlinics in
Accra, Tema, Kumasi, Obuasi, Agona, Mampong, Agogo,
Konongo and Nkawie (Ashanti Region), Nkawkaw and Atibie
(Eastern Region), and Assin Fosu and Dunkwa (Central Region).
Characterization of patients included i) the documentation of the
medical history on standardized structured questionnaires, includ-
ing self-reported duration of cough and symptoms of TB (dyspnea,
chest pain, night sweats, fever, hemoptysis, weight loss), ii) two
independent examinations of non-induced sputum specimens for
acid-fast bacilli, iii) serological determination of the HIV status and
confirmation of positive results by an alternative test system, iv)
culturing and molecular differentiation of phylogenetic mycobac-
terial lineages, and v) a posterior-anterior chest radiography.
Inclusion criteria were two sputum smears positive for acid-fast
bacilli, no history of previous TB or anti-mycobacterial treatment
and an age between 6 and 60 years. Two sputum smears were
examined in order to corroborate and confirm the phenotype.
Patients were also included if only one smear and the culture for
mycobacterial growth was positive. Exclusion criteria were
incomplete information provided on the questionnaire, HIV
positivity, evidence of alcoholism, drug addiction and other
apparent generalized disease. A total of 2010 patients fulfilling
the criteria for participation were enrolled.
Unrelated personal contacts of cases and community members
from neighboring houses of cases and public assemblies were
recruited as controls. The leading criterion for enrollment as a
control was no history of TB or previous anti-mycobacterial
treatment. Characterization of controls included a medical history,
posterior-anterior chest X-ray radiography and a tuberculin skin
test (Tuberculin Test PPD Me ´rieux, bioMe ´rieux, Nu ¨rtingen,
Germany). 1211 personal contacts and 1135 community members
fulfilled the criteria for participation and were available as controls.
Study participants belonged to the following ethnic groups
(cases/controls): Akan including Ashanti, Fante, Akuapem
(63.6%/59.1%), Ga-Adangbe (14.5%/19.8%), Ewe (7.1%/9.3%)
and ethnic groups of northern Ghana including Dagomba, Sissala,
Gonja, and Kusasi (12.9%/10.4%). The proportions of ethnicities
among patients and controls did not differ significantly.
Disclosure of HIV test results was dependent on the
documented willingness of participants to be informed and
included for HIV-positive patients their prompt referral to
counseling and treatment provided by the Ghanaian AIDS
Control Programme.
Typing of mycobacterial isolates
The firm diagnosis of pulmonary TB was made as described
previously [13,17,30]. M. tuberculosis complex isolates were cultured
on Lo ¨wenstein-Jensen (LJ) media and shipped to the German
National Reference Centre for Mycobacteria (Borstel, Germany)
for minute analyses of biochemical, growth and molecular
Figure 2. Comparison of pGL3 IRGM 2261C and pGL3 IRGM
2261T promoter constructs. FL/RL, ratio of firefly:Renilla luciferase
activity; pGL3 2261C, pGL3-Control Vector carrying the IRGM 2261C
wild-type variant; pGL3 2261T, pGL3-Control Vector carrying the IRGM
2261T variant; *, P 0.013.
doi:10.1371/journal.ppat.1000577.g002
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isolates included spoligotyping, IS6110 fingerprinting and typing
of the pks1/15 deletion as described previously [31–33].
Mycobacterial strains were for further stratification grouped
according to the major phylogenetic lineages [12].
The stepwise procedure of typing of mycobacteria included an
initial cluster analysis of IS6110 fingerprinting data and lineage
identification according to specific spoligotype signatures. Assign-
ment of lineages was based on the MIRU-VNTRplus webpage
(www.miru-vntrplus.org; [34]) and a reference strain collection
using the Bionumerics 5.1 software (Applied Maths, Sint-Martens-
Latem, Belgium). Classification was confirmed by random
selection of 20 strains of each group and testing for the presence
of lineage-specific deletions as follows: pks1/15 for M. tuberculosis
Euro-American, region of difference (RD) 239 for M. tuberculosis
East African Indian (EAI), RD9 and RD711 for M. africanum West
African 1, RD9 and RD702 for M. africanum West African 2, and
RD9 and RD4 for M. bovis. All M. tuberculosis strains with
ambiguous lineage identification were confirmed as belonging to
the Euro-American lineage by identifying the presence of the pks1/
15 7 bp deletion. Deletion typing was performed using protocols
available at the MIRU-VNTRplus webpage [34].
Clusters were defined as groups of affected individuals infected
with mycobacterial strains exhibiting the same IS6110 finger-
printing patterns. If less than 5 bands were identified, analyses
were supplemented by spoligotyping. Identical strains isolated
from 2 or more patients were regarded as a cluster and strains
found in 1 patient only were considered unique.
HIV testing
For HIV-1/-2 testing of TB cases, a capillary test system
(Capillus, Trinity Biotech, Bray, Co Wicklow, Ireland) was
applied. HIV positivity was confirmed by the Organon Teknika
Vironostika HIV-1/-2 EIA system (Organon Teknika, Turnhout,
Belgium). The rate of confirmation was 100%. HIV-positive TB
patients were excluded from further genetic analyses.
DNA re-sequencing of IRGM
DNA was isolated from peripheral blood samples of participants
(AGOWAH mag Maxi DNA Isolation Kit, Macherey & Nagel,
Germany) following the instructions of the manufacturer. The
reference sequence was derived from the chromosome 5 contig,
GenBank NW_922784.1, region 23935681…23938058. In order
to reliably identify the IRGM variants occurring in our study
population and to select variants for genotyping, a segment
containing 1053 bp of the 59UTR region upstream of the ATG
start codon including the intron and the Alu segment, the open
reading frame (ORF) of 546 coding bp and 250 bp of the 39 region
distal of the ORF of the IRGM gene were sequenced. Sequence
analysis was performed in 23 TB patients, 23 PPD-positive and in
23 PPD-negative controls. Sequencing reactions were run on an
automated ABI 3100 DNA sequencer (Applied Biosystems, Foster
City, USA). Forward (F) and reverse (R) primers for re-sequencing
were IRGM_pro1000F ccttgaaaaagagcagagcatt and IRGM_-
pro1000R tagcatccccagccctca (598 bp), IRGM_pro500F
ttgctccctgaagaaatgtg and IRGM_pro500R ctcaacattcatggcttcca
(599 bp), IRGM_p1F aatatctgcgtccagggttc and IRGM_p1R
tgaactgcatttccatcagg (572 bp) and IRGM_p2F tgtgcctcctatttctcttcc
and IRGM_p2 tgatataatcttgcatccattttaag (600 bp).
IRGM variants selected for genotyping
Based on the results of re-sequencing and evidence of
association of with other conditions, eight IRGM variants were
selected for genotyping (Table 6). The variant at position 2566G/
C (rs17111379) was chosen for genotyping, as this variant was by
re-sequencing identified in the groups of TB cases and PPD-
positive controls only. Notably, IRGM 2566 allele frequencies are
unevenly distributed between Caucasians and the West African
Table 6. Primer Pairs and sensor/anchor oligonucleotides for LightTyper-based IRGM genotyping.
IRGM Variant, rs # Localization Primer oligonucleotides Sensor/Anchor oligonucleotides
20.1 kb deletion WT/DEL na upstream F1-GCACTGGTGGACAGGTAA S-Cy5-GGCTTTTTCTGTGACCATGTCTGTGAAC-phosphate
224525–24423 F2-CATTTACAGTAGTATCAAAAGAATAAAAACAATTTTATTTAAA
R-TGCTTGGGTACGACACG A-6-Fam-TGTGGGAGGTCAGCAGAAAACCCTATAGTTTTCC
24299 C/T, rs13361189 upstream F-CCCACACTCACCATGGA S-AATCGGATGTATATTAGTAGACCCCGTG-6-Fam
R-ACATAGTACACTTTGTGTGTTG A-Cy5-CAGCGGGTACAGTTTAGAAAGGGAAGTT-phosphate
2566 G/C, rs17111379 intron F-CTGCTTTGGAGGCTGAC S-Cy5-CTCCCTGAACAAATGTGCACATTG-phosphate
R-AGGTTAAGGATGCAGCTAATAG A- AGGGCGTTCCTCAGGGACCCTACCTTTCTT-6-Fam
2420 C/T, ss105106763 intron F-CTGCTTTGGAGGCTGAC S-TCACCTGCTCTTCTACTTCCGC-6-Fam
R-AGGTTAAGGATGCAGCTAATAG A-Cy5-GCTTACTCCAGTGCCCACAGATACGACAG-phosphate
repeat 1–4, rs60800371 Alu sequence F-CATCCTAACTCACCTGCTCTTCTA S-6-Fam-TAAGCATTGGGTTTTGTTTGTTTGTTTGTTTGTTTTGAGA
2308–2311/2319/2323 R-TGTTAGAGATCACCTCTGGCAA A-Cy5-GGAGTCTTGCTCTGTTGCCAGGCTGGAG-phosphate
2261 C/T, rs9637876 Alu sequence F-CCAGTGCCCACAGATAC S-CTGGAGTGCAATGGCGTGAT-6-Fam
R-CAGCTAATACAGGAGGCTGA A-Cy5-TCAGCTCACTGCAATATCTGCGTCCAGGG-phosphate
271 A/G, rs9637870 Alu sequence FCACGCGCAGCTAATTTTTTTGTATTTTA S-Cy5-CACTTTGGAAGGCCGAGGCGA-phosphate
R-TTCAGAGTCTCCTTGATGTTA A-6-Fam-CGCCGTGGCTCATGCCTGTAATCCC
313 C/T, rs10065172 Exon 1 F-CCTCACCTCCTACTGAGC S-GAGAACTACCTGATGGAAATGCAGTTCA-6-Fam
R-TTTCCCATGTCCTCAGCG A-Cy5-CCGGTATGACTTCATCATGGTTGCATCTGCACA-phosphate
F, forward primer; R, reverse primer; F1, F2, two forward primers applied for the assessment of the 20.1 kb deletion; S, sensor oligonucleotide; A, anchor oligonucleotide;
na, not available; 6–Fam, 6–carboxyfluorescein; Cy5, corresponding to the Roche fluorophore LC Red 640; synthesized by biomers.net GmbH, Ulm, Germany.
doi:10.1371/journal.ppat.1000577.t006
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Nigeria: G 0.74, C 0.26; www.hapmap.org/cgi-perl/snp_details?
name=rs17111379&source=hapmap_B35). The variant at posi-
tion 2420C/T (ss105106763) was included as it was identified as a
novel variant in our study population and was not in strong linkage
with other polymorphisms. The IRGM variant 2261 (rs9637876)
was selected for genotyping, because, according to an in silico
prediction of transcription factor binding properties, the allele
causes loss of several binding sites (PAX5, ARNT, AHR;
http://alggen.lsi.upc.es/recerca/menu_recerca.html). IRGM 271
(rs9637870) and the microsatellite repeat (rs60800371; repeats
starting at position 2308) are in LD with IRGM 2261 and were
included in genotyping to more reliably identify a potentially
causative variant. The synonymous exonic variant 313C/T
(L105L; rs10065172), the 20.1 kb deletion and the variant located
124 bp downstream of the 20.1 kb deletion (rs13361189; position
24299) were included in the genotyping panel due to their proven
association with Crohn’s disease [9–11].
Further variants that were identified by DNA re-sequencing
were not subjected to genotyping, as they were either in perfect
LD with +313 (2964A/C, 2787C/T, +87A/G), or too low in
their frequencies to allow for reasonable statistical calculations
(2908A/C, 2844C/T, 2797C/T, 2386/7delAG, 2284G/A,
281C/A, 370A/G, +2T/C, +106C/T).
Genotyping of IRGM variants
IRGM variants were analyzed by dynamic allele-specific
hybridization with fluorescence resonance energy transfer (FRET)
in a LightTyper device (Roche Diagnostics, Mannheim, Ger-
many). Primer pairs, sensor- and anchor-oligonucleotides utilized
are listed in Table 6.
As no frequency information was available for the occurrence of
the IRGM 2261 polymorphism among Caucasians, this variant
was also genotyped in 47 healthy voluntary German individuals
(employees of the Bernhard Nocht Institute for Tropical Medicine,
Hamburg; informed consent obtained).
For the microsatellite repeat, a FRET-based LightTyper
method was developed using a sensor nucleotide that covered
the entire tetranucleotide repeat with adjacent 59- and 39-
nucleotides [15]. Depending on the actual number of the repeats,
distinct melting temperatures allow explicit specification of the
number of repeats. For the 20.1 kb deletion upstream of the IRGM
promoter, the LightTyper design was combined with a gap-PCR
comprising two forward primers matching upstream and within
the region of deletion. The assay enabled the determination of
gene fragments with and without the 20.1 kb deletion.
Plasmid construction and reporter gene assay
All plasmid constructions were based on the pGL3-Control
Vector (Promega, Mannheim, Germany) which contains the SV40
promoter driving the firefly luciferase gene. Two fragments, each
of 0.4 kb, comprising the Alu-repeat sequence and, thus, including
the IRGM variants of interest, 2261C or 2261T, were PCR-
amplified with oligonucleotide primers 59-cgaagctttcacactctat-
tagctgcatccttaac-39 and 59-cgccatggctttctcaacattcatggcttccat-39
from 10 ng of genomic human DNA (Biomers.net GmbH, Ulm
Germany).
PCR conditions were: Initial denaturation (98uC, 309), 30
amplification cycles (98uC, 79;6 4 uC2 0 9;7 2 uC, 359) and final
elongation (72uC, 79). HindIII and NcoI restriction sites at the 59
and 39 end, respectively, were engineered on each PCR product.
Fragments were then ligated into the HindIII-NcoI digested pGL3-
Control Vector to generate plasmids pGL3 2261C and pGL3
2261T. Enzymatic digestions and ligations were performed
according to the instructions of the manufacturer. Small-scale
preparations were done applying the NucleoSpin Plasmid Kit
(Macherey and Nagel, Du ¨ren, Germany). Plasmid DNAs were
propagated in E. coli XL1- Blue cells (Stratagene, La Jolla, CA,
USA) and prepared using the EndoFree Plasmid Maxi Kit
(Quiagen, Hilden, Germany). DNA sequences of the final
constructs were confirmed by sequencing.
1610
6 cells of the human monocytic cell line THP1 (German
Resource Centre for Biological Material, DMSZ, Braunschweig,
Germany) were transfected with either 0.5 mg of the two plasmid
constructs, with the addition of 0.5 mg of the plasmid phRL-CMV
which contains the gene encoding Renilla luciferase (Promega,
Mannheim, Germany) in order to normalize results. Transfectiosn
with 0.5 mg of the unmodified pGL3-Control Vector and 0.5 mg
phRL-CMV, as well as a mock transfection, were performed for
control and to minimize effects of reagents on the cells. All
transfections were performed with the Amaxa Cell Line
Nucleofector Kit V (Lonza, Cologne, Germany). Four hours after
transfection, cells were harvested and luciferase activities were
measured (Dual-Luciferase Reporter Assay System; Promega,
Mannheim, Germany). Firefly luminescence was measured using a
single tube Junior LB9509 luminometer (Berthold Technologies,
Bad Wildbad, Germany). After a 10 second measurement period,
100 ml1 6 Stop & Glo Reagent were added for the detection of
Renilla luminescence. Measurements of luminescence are ex-
pressed as relative light units (RLU). For each variant, five
independent transfections were performed.
Databases, statistics
Demographic data, self-reported signs and symptoms as
documented on structured questionnaires as well as laboratory
results were double-entered into a Fourth Dimension database
(San Jose, CA, USA). Bacteriological data were provided as Excel
datasheets. Data were locked before using them in a pseudony-
mized form for statistical analyses. Power calculations were
performed with the public CATS software (http://www.sph.
umich.edu/csg/abecasis/CaTS/).
Multivariate logistic regression analyses were calculated for
different models to determine odds ratios (OR) for allele and
genotype distributions (STATA 10.0MP software; Stata Corporation,
College Station, TX, USA). As age, sex and ethnicity were significant
confounders, they were appropriately adjusted for. Analyses of allele
distributions and Hardy-Weinberg equilibria (HWE) were calculated
with a public STATA module (www-gene.cimr.cam.ac.uk/clayton/
software/stata/genassoc; David Clayton, Cambridge, UK). Haplo-
types were estimated with the UNPHASED software (version 3.0.13;
Frank Dudbridge, http://www.mrc-bsu.cam.ac.uk/personal/frank/
software/unphased/),whereby incompletehaplotypesweresubjected
to simulations comprising all possible haplotypic completions of
available data. In order to verify the independence of ORs that were
obtained for associations of different mycobacterial clades/genotypes
with phenotypes,ORs were subjected to tests of interaction according
to the method described in [16].
Corrections of nominal P values (Pnom) for multiple testing
applied to the number of variants tested and when stratifications
by mycobacterial lineages were made. Bonferroni corrected P
values (Pcorr),0.05 were considered significant and correction
values are indicated where applicable.
The tetranucleotide repeat rs60800371 and SNPs at positions
2261 (rs9637876) and 271 (rs9637870) are in strong LD (r
2,0.8)
and were, therefore, combined as a single correction entity. Global
P values of haplotype associations and of distinct haplotypes were
subjected to 1000 permutations (UNPHASED software).
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calculated to confirm a normal distribution and differences in
the ratio of firefly:Renilla luciferase activity in the reporter gene
assay.
Accession numbers
Genes and genomic contig. Immunity-related GTPase
family, M; IRGM (NCBI BC128168.1); Homo sapiens
chromosome 5 genomic contig (NCBI NW_922784.1).
Protein. Immunity-related GTPase family, M; IRGM (NCBI
NP_001139277).
Transcription factors. Aryl hydrocarbon receptor nuclear
translocator; ARNT; (HUGO Gene Nomenclature Committee,
[HGNC] HGNC:700); Aryl hydrocarbon receptor; AHR (HGNC
HGNC:348); Paired box 5; PAX5 (HGNC HGNC:8619);
Forkhead box P3; FOXP3 (HGNC HGNC:6106); Nuclear
receptor subfamily 3, group C, member 1/glucocorticoid
receptor; GR (HGNC HGNC:7978); Progesterone receptor/
PGR; PR A/PR B (HGNC HGNC:8910).
Single nucleotide polymorphisms. Deletion (not available);
24299 C.T (NCBI rs13361189); 2964 A.C (NCBI
rs10059011); 2908 A.C (NCBI ss105106760); 2844 T.C
(NCBI rs10052068); 2797 C.T (NCBI ss105106761); 2787
T.C (NCBI rs17111376); 2566 G.C (NCBI rs17111379); 2420
C.T (NCBI ss105106763); 2386/387 AG.del (NCBI
ss105106769); 2308 1, 3 or 4 ‘GTTT’ (NCBI rs60800371);
2284 G.A (NCBI ss105106764); 2261 C.T (NCBI rs9637876);
271 G.A (NCBI rs9637870); 281 C.A (NCBI ss105106765);
313 C.T (NCBI rs10065172); 370 A.G (NCBI ss105106766); +2
T.C (NCBI ss105106767); +87 G.A (NCBI rs7705542); +106
T.C (NCBI ss105106768).
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